All News #Library
Biotech
Amplia Therapeutics Enhances Accent Pancreatic Cancer Trial
23 Mar 2026 //
GLOBENEWSWIRE
Narmafotinib Shows Combo Benefits in KRAS Models
09 Mar 2026 //
GLOBENEWSWIRE
Amplia Opens U.S. Sites for Amplicity Pancreatic Cancer Trial
11 Feb 2026 //
GLOBENEWSWIRE
Amplia Therapeutics Releases Q3 Activities and Cash Flow Report
30 Jan 2026 //
GLOBENEWSWIRE
ACCENT DATA Showcased AT 2026 ASCO GI Cancer Symposium
12 Jan 2026 //
GLOBENEWSWIRE
Amplia Partners Next&Bio For FAK And Kras Inhibitor Combo Therapy
19 Dec 2025 //
GLOBENEWSWIRE

Market Place
Sourcing Support